CD3
Second transplant
TCRαβ
depleted HSCT
graft dysfunction
inborn errors of immunity
Journal
Transplantation and cellular therapy
ISSN: 2666-6367
Titre abrégé: Transplant Cell Ther
Pays: United States
ID NLM: 101774629
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
01
04
2023
revised:
13
05
2023
accepted:
25
05
2023
medline:
1
8
2023
pubmed:
7
6
2023
entrez:
6
6
2023
Statut:
ppublish
Résumé
A minority of children experience significant graft dysfunction after undergoing allogeneic hematopoietic stem cell transplantation (HSCT) for inborn errors of immunity (IEI). The optimal approach to salvage HSCT in this scenario is unclear with respect to conditioning regimen and stem cell source. This single-center retrospective case series reports the outcomes of salvage CD3
Identifiants
pubmed: 37279857
pii: S2666-6367(23)01321-0
doi: 10.1016/j.jtct.2023.05.019
pii:
doi:
Substances chimiques
Receptors, Antigen, T-Cell, alpha-beta
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
513.e1-513.e9Informations de copyright
Crown Copyright © 2023. Published by Elsevier Inc. All rights reserved.